Registry for neuromuscular disorder patients in Switzerland
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study is a patient registry that collects health information from people diagnosed with a neuromuscular disorder in Switzerland. It helps researchers better understand these conditions and how they vary from person to person.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of a neuromuscular disorder
- You must live in Switzerland or receive treatment there
- You must be able to give informed consent (or have consent provided as appropriate)
- Your diagnosis should be confirmed when possible by genetic testing
- If genetic testing isn’t available, your diagnosis should be supported by standard tests like biopsy and/or nerve/muscle electrical testing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is a registry that collects health information from people with spinal muscular atrophy (SMA). It helps researchers understand the condition better and may support future studies and treatments.
This registry enrolls people with a confirmed diagnosis of multiple sclerosis (MS) who are age 18 or older and live in Switzerland (or receive their MS care there). It helps researchers better understand MS in the Swiss population and may improve future studies and care.
This registry study collects information about people with cerebral palsy in Switzerland. It helps researchers better understand CP and related needs over time, which can support future care and studies.
This study builds a “registry,” which is a secure list of people with rare diseases or suspected rare diseases in Switzerland. It helps researchers better understand these conditions over time and improve care.
This study is a registry that collects health information from children and teens in Switzerland diagnosed with certain inflammatory brain and spinal cord conditions. It helps researchers understand these illnesses better over time and may guide future treatments.
This study keeps a registry (a secure list) of adults with diabetes. It collects information over time to better understand diabetes and support care—your participation is voluntary.
Hear when a new SMA trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.